The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
DNA Diagnostics & Testing-Global Market Insights and Sales Trends 2025
Synopsis
The global DNA Diagnostics & Testing market size is expected to reach US$ 10120 million by 2029, growing at a CAGR of -0.2% from 2023 to 2029. The market is mainly driven by the significant applications of DNA Diagnostics & Testing in various end use industries. The expanding demands from the Oncology Diagnostics & Histopathology, Identity Diagnostics & Forensics and Pharmacogenomics Diagnostic Testing & Drug Metabolism,, are propelling DNA Diagnostics & Testing market. PCR Based Diagnostics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the NGS DNA Diagnosis segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for DNA Diagnostics & Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global DNA Diagnostics & Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global DNA Diagnostics & Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, DNA Diagnostics & Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of DNA Diagnostics & Testing covered in this report include Abbott Laboratories, Affymetrix Inc., Agilent Technologies Inc, Applied Biosystems Group, Illumina Inc., Cepheid Inc., Hologic, Bio-Rad Laboratories and Dako, etc.
The global DNA Diagnostics & Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Affymetrix Inc.
Agilent Technologies Inc
Applied Biosystems Group
Illumina Inc.
Cepheid Inc.
Hologic
Bio-Rad Laboratories
Dako
Abbott
Roche Diagnostics
Beckman Coulter Inc.
Siemens Healthcare
Global DNA Diagnostics & Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global DNA Diagnostics & Testing market, Segment by Type:
PCR Based Diagnostics
NGS DNA Diagnosis
In-situ Hybridization Diagnostics
Micro-arrays Based Diagnostics
Global DNA Diagnostics & Testing market, by Application
Oncology Diagnostics & Histopathology
Identity Diagnostics & Forensics
Pharmacogenomics Diagnostic Testing & Drug Metabolism
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of DNA Diagnostics & Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global DNA Diagnostics & Testing market size is expected to reach US$ 10120 million by 2029, growing at a CAGR of -0.2% from 2023 to 2029. The market is mainly driven by the significant applications of DNA Diagnostics & Testing in various end use industries. The expanding demands from the Oncology Diagnostics & Histopathology, Identity Diagnostics & Forensics and Pharmacogenomics Diagnostic Testing & Drug Metabolism,, are propelling DNA Diagnostics & Testing market. PCR Based Diagnostics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the NGS DNA Diagnosis segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for DNA Diagnostics & Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global DNA Diagnostics & Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global DNA Diagnostics & Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, DNA Diagnostics & Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of DNA Diagnostics & Testing covered in this report include Abbott Laboratories, Affymetrix Inc., Agilent Technologies Inc, Applied Biosystems Group, Illumina Inc., Cepheid Inc., Hologic, Bio-Rad Laboratories and Dako, etc.
The global DNA Diagnostics & Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Affymetrix Inc.
Agilent Technologies Inc
Applied Biosystems Group
Illumina Inc.
Cepheid Inc.
Hologic
Bio-Rad Laboratories
Dako
Abbott
Roche Diagnostics
Beckman Coulter Inc.
Siemens Healthcare
Global DNA Diagnostics & Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global DNA Diagnostics & Testing market, Segment by Type:
PCR Based Diagnostics
NGS DNA Diagnosis
In-situ Hybridization Diagnostics
Micro-arrays Based Diagnostics
Global DNA Diagnostics & Testing market, by Application
Oncology Diagnostics & Histopathology
Identity Diagnostics & Forensics
Pharmacogenomics Diagnostic Testing & Drug Metabolism
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of DNA Diagnostics & Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of DNA Diagnostics & Testing
1.1 DNA Diagnostics & Testing Market Overview
1.1.1 DNA Diagnostics & Testing Product Scope
1.1.2 DNA Diagnostics & Testing Market Status and Outlook
1.2 Global DNA Diagnostics & Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global DNA Diagnostics & Testing Market Size by Region (2018-2029)
1.4 Global DNA Diagnostics & Testing Historic Market Size by Region (2018-2023)
1.5 Global DNA Diagnostics & Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, DNA Diagnostics & Testing Market Size (2018-2029)
1.6.1 North America DNA Diagnostics & Testing Market Size (2018-2029)
1.6.2 Europe DNA Diagnostics & Testing Market Size (2018-2029)
1.6.3 Asia-Pacific DNA Diagnostics & Testing Market Size (2018-2029)
1.6.4 Latin America DNA Diagnostics & Testing Market Size (2018-2029)
1.6.5 Middle East & Africa DNA Diagnostics & Testing Market Size (2018-2029)
2 DNA Diagnostics & Testing Market by Type
2.1 Introduction
2.1.1 PCR Based Diagnostics
2.1.2 NGS DNA Diagnosis
2.1.3 In-situ Hybridization Diagnostics
2.1.4 Micro-arrays Based Diagnostics
2.2 Global DNA Diagnostics & Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global DNA Diagnostics & Testing Historic Market Size by Type (2018-2023)
2.2.2 Global DNA Diagnostics & Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America DNA Diagnostics & Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe DNA Diagnostics & Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific DNA Diagnostics & Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America DNA Diagnostics & Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa DNA Diagnostics & Testing Revenue Breakdown by Type (2018-2029)
3 DNA Diagnostics & Testing Market Overview by Application
3.1 Introduction
3.1.1 Oncology Diagnostics & Histopathology
3.1.2 Identity Diagnostics & Forensics
3.1.3 Pharmacogenomics Diagnostic Testing & Drug Metabolism
3.2 Global DNA Diagnostics & Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global DNA Diagnostics & Testing Historic Market Size by Application (2018-2023)
3.2.2 Global DNA Diagnostics & Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America DNA Diagnostics & Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe DNA Diagnostics & Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific DNA Diagnostics & Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America DNA Diagnostics & Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa DNA Diagnostics & Testing Revenue Breakdown by Application (2018-2029)
4 DNA Diagnostics & Testing Competition Analysis by Players
4.1 Global DNA Diagnostics & Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in DNA Diagnostics & Testing as of 2022)
4.3 Date of Key Players Enter into DNA Diagnostics & Testing Market
4.4 Global Top Players DNA Diagnostics & Testing Headquarters and Area Served
4.5 Key Players DNA Diagnostics & Testing Product Solution and Service
4.6 Competitive Status
4.6.1 DNA Diagnostics & Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories DNA Diagnostics & Testing Products, Services and Solutions
5.1.4 Abbott Laboratories DNA Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Affymetrix Inc.
5.2.1 Affymetrix Inc. Profile
5.2.2 Affymetrix Inc. Main Business
5.2.3 Affymetrix Inc. DNA Diagnostics & Testing Products, Services and Solutions
5.2.4 Affymetrix Inc. DNA Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Affymetrix Inc. Recent Developments
5.3 Agilent Technologies Inc
5.3.1 Agilent Technologies Inc Profile
5.3.2 Agilent Technologies Inc Main Business
5.3.3 Agilent Technologies Inc DNA Diagnostics & Testing Products, Services and Solutions
5.3.4 Agilent Technologies Inc DNA Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Applied Biosystems Group Recent Developments
5.4 Applied Biosystems Group
5.4.1 Applied Biosystems Group Profile
5.4.2 Applied Biosystems Group Main Business
5.4.3 Applied Biosystems Group DNA Diagnostics & Testing Products, Services and Solutions
5.4.4 Applied Biosystems Group DNA Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Applied Biosystems Group Recent Developments
5.5 Illumina Inc.
5.5.1 Illumina Inc. Profile
5.5.2 Illumina Inc. Main Business
5.5.3 Illumina Inc. DNA Diagnostics & Testing Products, Services and Solutions
5.5.4 Illumina Inc. DNA Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Illumina Inc. Recent Developments
5.6 Cepheid Inc.
5.6.1 Cepheid Inc. Profile
5.6.2 Cepheid Inc. Main Business
5.6.3 Cepheid Inc. DNA Diagnostics & Testing Products, Services and Solutions
5.6.4 Cepheid Inc. DNA Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Cepheid Inc. Recent Developments
5.7 Hologic
5.7.1 Hologic Profile
5.7.2 Hologic Main Business
5.7.3 Hologic DNA Diagnostics & Testing Products, Services and Solutions
5.7.4 Hologic DNA Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Hologic Recent Developments
5.8 Bio-Rad Laboratories
5.8.1 Bio-Rad Laboratories Profile
5.8.2 Bio-Rad Laboratories Main Business
5.8.3 Bio-Rad Laboratories DNA Diagnostics & Testing Products, Services and Solutions
5.8.4 Bio-Rad Laboratories DNA Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Bio-Rad Laboratories Recent Developments
5.9 Dako
5.9.1 Dako Profile
5.9.2 Dako Main Business
5.9.3 Dako DNA Diagnostics & Testing Products, Services and Solutions
5.9.4 Dako DNA Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Dako Recent Developments
5.10 Abbott
5.10.1 Abbott Profile
5.10.2 Abbott Main Business
5.10.3 Abbott DNA Diagnostics & Testing Products, Services and Solutions
5.10.4 Abbott DNA Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Abbott Recent Developments
5.11 Roche Diagnostics
5.11.1 Roche Diagnostics Profile
5.11.2 Roche Diagnostics Main Business
5.11.3 Roche Diagnostics DNA Diagnostics & Testing Products, Services and Solutions
5.11.4 Roche Diagnostics DNA Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.11.5 Roche Diagnostics Recent Developments
5.12 Beckman Coulter Inc.
5.12.1 Beckman Coulter Inc. Profile
5.12.2 Beckman Coulter Inc. Main Business
5.12.3 Beckman Coulter Inc. DNA Diagnostics & Testing Products, Services and Solutions
5.12.4 Beckman Coulter Inc. DNA Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.12.5 Beckman Coulter Inc. Recent Developments
5.13 Siemens Healthcare
5.13.1 Siemens Healthcare Profile
5.13.2 Siemens Healthcare Main Business
5.13.3 Siemens Healthcare DNA Diagnostics & Testing Products, Services and Solutions
5.13.4 Siemens Healthcare DNA Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.13.5 Siemens Healthcare Recent Developments
6 North America
6.1 North America DNA Diagnostics & Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe DNA Diagnostics & Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific DNA Diagnostics & Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America DNA Diagnostics & Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa DNA Diagnostics & Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 DNA Diagnostics & Testing Market Dynamics
11.1 DNA Diagnostics & Testing Industry Trends
11.2 DNA Diagnostics & Testing Market Drivers
11.3 DNA Diagnostics & Testing Market Challenges
11.4 DNA Diagnostics & Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
